Shareholders of Revance Therapeutics, Inc. Should Contact Levi & Korsinsky Before March 4, 2025 to Discuss Your Rights – RVNC
Portfolio Pulse from
Levi & Korsinsky, LLP has announced a class action securities lawsuit against Revance Therapeutics, Inc. (NASDAQ: RVNC). Shareholders are encouraged to contact the firm before March 4, 2025, to discuss their rights.
February 18, 2025 | 7:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
A class action lawsuit has been filed against Revance Therapeutics, Inc. Shareholders should contact Levi & Korsinsky by March 4, 2025, to discuss their rights.
The announcement of a class action lawsuit typically has a negative impact on a company's stock price due to potential legal liabilities and associated costs. Investors may react negatively, leading to a short-term decline in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100